STAT

MAY 17, 2023

WASHINGTON — A key House panel on Wednesday advanced several health care bills on Wednesday, including its first step toward a controversial effort to equalize Medicare payments between hospitals and physician offices.

Hospitals 251

Hospitals Physician Offices Drug Pricing 251

STAT

JANUARY 17, 2023

retail drug purchases. Continue to STAT+ to read the full story…

Drug Pricing 258

Drug Pricing Hospitals 258

STAT

OCTOBER 18, 2024

WASHINGTON — Californians are about to vote on an aggressive policy proposals to reform a drug discount program that is a key source of revenue for hospitals and health clinics. The 340B Drug Discount Program is no exception.   The group behind it? Apartment builders. 

Drug Pricing 280

Drug Pricing Hospitals 280

STAT

JANUARY 30, 2023

In a victory for the pharmaceutical industry, a federal appeals court ruled drug companies have the right to limit discounts to hospitals that rely on numerous contract pharmacies as they participate in a U.S. government drug discount program.

Hospitals 267

Hospitals Drug Pricing 267

STAT

NOVEMBER 8, 2023

WASHINGTON — A prominent Senate panel on Wednesday passed a new package of health policy reforms that would rein in certain pharmacy middlemen practices and ensure Medicare patients aren’t paying more than insurers do for medications. The package passed the committee 26-0 with no amendments added. Ron Johnson (R-Wis.)

Hospitals 303

Hospitals Packaging Drug Pricing 303

STAT

MARCH 17, 2025

Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. The agency also maintained Roche disseminated “erroneous information” about using biosimilars in combination therapy.

Biosimilars 171

Biosimilars Hospitals Pharmaceutical Companies Pharmaceutical Companies 171

STAT

OCTOBER 28, 2022

 Over the past week, Areva Pharmaceuticals began marketing vials of fludarabine at a wholesale price of $2,736, much more than the $272 charged for the same dosage by Fresenius Kabi and the $109 price from Teva Pharmaceuticals.

Drug Pricing 246

Drug Pricing Dosage Chemotherapy Hospitals 246

pharmaphorum

JUNE 6, 2022

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that provides patients access to medications at a lower cost. . “Manufacturers get a bad rap as being the source of high pricing for patient meds. .”

Drug Pricing 144

Drug Pricing Online Pharmacies Labelling Hospitals 144

STAT

FEBRUARY 14, 2024

The Federal Trade Commission is launching a probe into the extent to which group purchasing organizations and wholesalers may contribute to ongoing shortages of key medicines at hospitals and other facilities across the country. Three group purchasing organizations, or GPOs, buy drugs on behalf of most hospitals in the U.S.,

Nursing Homes 346

Nursing Homes Hospitals Chemotherapy Drug Pricing 346

PhRMA

FEBRUARY 21, 2023

There have been some alarming stories uncovered by the media on ways nonprofit hospitals — many of which participate in the 340B drug pricing program — are taking advantage of the system and their tax-exempt status to boost their bottom lines, at the expense of patients. Here are some recent articles exposing this issue:

Hospitals 122

Hospitals Drug Pricing 122

STAT

SEPTEMBER 14, 2023

WASHINGTON — A nonprofit formed by hospitals to deal with drug shortages is considering a move into chemotherapies. Frustrated by drug shortages and the price spikes that typically ensue, executives from large hospital systems launched the nonprofit Civica Rx to deal with the problem in September 2018.

Hospitals 309

Hospitals Chemotherapy Drug Pricing 309

PhRMA

APRIL 24, 2023

Nonprofit hospitals are supposed to help provide access to crucial treatment and services in our most vulnerable communities. But recent research adds to the mountain of evidence showing nonprofit hospitals continue to fall short in their community benefit.

Hospitals 102

Hospitals Drug Pricing 102

STAT

OCTOBER 18, 2024

The data mark a steady rise in sales under the 340B Drug Discount Program, which requires drugmakers to offer discounts that are typically estimated to be 25% to 50% — but could be higher — off all outpatient drugs to hospitals and clinics that primarily serve lower-income patients. billion in 2016.

Hospitals 318

Hospitals Drug Pricing 318

STAT

SEPTEMBER 18, 2024

government agency has threatened Johnson & Johnson with sanctions if the company proceeds with plans to alter payment methods for some hospitals that participate in a federal drug discount program , STAT reports. We hope you have a wonderful day, and please do keep in touch. … A U.S.

Hospitals 261

Hospitals Drug Pricing Diabetes 261

STAT

AUGUST 15, 2024

When rheumatoid arthritis patients enroll in Medicare, switching from private insurance plans, self-administered medications such as Humira and Xeljanz become unaffordable overnight, thanks to the program’s convoluted pricing of at-home prescription drugs.   Read the rest…

Hospitals 351

Hospitals Drug Pricing 351

STAT

DECEMBER 14, 2024

government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceutical company has been threatened with such a step. The move came after Sanofi disclosed last month that, as of Jan.

Hospitals 252

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 252

Drug Channels

JUNE 4, 2024

Meanwhile, employment and salaries in non-retail settings—hospitals, physician offices, outpatient centers, and home healthcare—continued to grow. What’s ahead for 340B-eligible hospitals? Find out during The 340B Drug Pricing Program: Trends, Controversies, and Outlook , a new live video webinar with Adam J.

Hospitals 98

Hospitals Physician Offices Drug Pricing 98

STAT

APRIL 2, 2024

Medicare on a couple of occasions recently has had to deal with billing forms that don’t provide adequate space for prices. Continue to STAT+ to read the full story…

Hospitals 354

Hospitals Drug Pricing 354

STAT

DECEMBER 5, 2023

Drug shortages are particularly vexing because they’re mostly caused by policies within the control of the government, as opposed to outside shocks such as natural disasters.

Hospitals 274

Hospitals Drug Pricing 274

Drug Channels

SEPTEMBER 28, 2021

Curl up with your favorite pumpkin-spiced blog and savor these stories harvested from the Drug Channels patch: Fresh insights about hospitals’ specialty drug profits SSR Update: Drug prices keep dropping My $0.02 d/b/a Drug Channels Institute. Autumn is here!

Drug Pricing 81

Drug Pricing Hospitals Biosimilars 81

STAT

FEBRUARY 22, 2024

A litmus test for states’ drug pricing power Colorado could soon cap how much the state will pay for Amgen’s autoimmune drug Enbrel — in what would be the first such move from a state prescription drug affordability board.

Drug Pricing 235

Drug Pricing Hospitals 235

STAT

JUNE 21, 2023

Drug middlemen once again were on the hot seat at a congressional hearing on Wednesday. The hearing by the House Education and Workforce health subcommittee was about consolidation in the hospital and health insurance sectors.

Hospitals 248

Hospitals Drug Pricing 248

STAT

NOVEMBER 3, 2023

I was living on the precipice of end-stage disease when I enrolled in the clinical trial that resulted in the historically fast Food and Drug Administration approval for the game-changing cystic fibrosis drug Trikafta. Five years later, the worst parts of my CF are gone. A decade ago, I would have had a vastly different outcome.

Hospitals 341

Hospitals Drug Pricing 341

STAT

DECEMBER 19, 2023

Today, a hospital in Barcelona goes rogue with its own CAR-T treatments, we learn more about Wegovy’s anti-inflammatory mechanisms, and more. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox.

Hospitals 251

Hospitals Drug Pricing Drug Development 251

STAT

APRIL 24, 2024

health care system to affordable medications,” said Benjamin Rome, one of the study authors and a faculty member at the Program on Regulation, Therapeutics, and Law at Harvard Medical School and Brigham and Women’s Hospital. “The fact that it’s so hard to find savings consistently is disappointing.”

Biosimilars 331

Biosimilars Medical Schools Hospitals Drug Pricing 331

STAT

JULY 31, 2024

I was caring for a man admitted to the hospital with uncontrolled atrial fibrillation, an irregular and often rapid heartbeat.

Medical Schools 291

Medical Schools Hospitals Drug Pricing 291

Drug Channels

DECEMBER 5, 2023

The common factor behind these two disparate situations: Pharmaceutical wholesalers’ unusual pricing for brand-name drugs sold to pharmacies, hospitals, and other buyers. Below, I walk through the economic fundamentals to help you understand another obscure aspect of our opaque drug pricing system.

Drug Pricing 98

Drug Pricing Hospitals 98

STAT

MARCH 9, 2023

The groups argue that the federal drug discount program has expanded beyond its original mission to help low-income and other vulnerable populations, and instead is benefiting large, well-resourced hospitals. Continue to STAT+ to read the full story…

Hospitals 245

Hospitals Drug Pricing 245

STAT

JANUARY 19, 2023

In a bid to blunt competition and address rising drug costs, Sanofi is offering a warranty that will cover the cost for any hospital if a specific medicine fails to work, marking only the second time a major pharmaceutical company has taken such a step.

Hospitals 257

Hospitals Pharmaceutical Companies Pharmaceutical Companies Drug Pricing 257

Drug Channels

AUGUST 15, 2022

Here’s a summer surprise for fans of the 340B Drug Pricing Program: Drug Channels has just obtained the 2021 figures from the Health Resources and Services Administration (HRSA)! Hospitals accounted for 87% of these skyrocketing 340B purchases. The data tell a familiar story. billion —an astonishing $5.9 billion (+$7.0

Hospitals 98

Hospitals Drug Pricing 98

STAT

SEPTEMBER 19, 2023

About last night… House leadership last night canceled a scheduled vote on a health care package that included transparency requirements for hospitals and insurers, reforms to some PBM practices, and a small site-neutral payment policy for administering drugs, Rachel writes. Continue to STAT+ to read the full story…

Packaging 266

Packaging Hospitals Drug Pricing 266

STAT

JUNE 28, 2023

“Oftentimes we can cure kids of their disease, but we can’t do that without the drugs,” said Unguru, a pediatric hematologist oncologist at Children’s Hospital at Sinai in Baltimore and the Johns Hopkins School of Medicine. “It’s just so, so maddening.”

Chemotherapy 256

Chemotherapy Hospitals Drug Pricing 256

STAT

APRIL 25, 2024

A hospital takes a gene therapy’s approval into its own hands What happens if, as an academic, you develop a promising gene therapy, but no company is willing to take it to market? It’s a busy day for pharma earnings:  Merck ,  Sanofi ,  Daiichi Sankyo ,  Astellas , and  Bristol Myers Squibb.

Hospitals 276

Hospitals Drug Pricing 276

PhRMA

OCTOBER 20, 2022

The 340B Drug Pricing Program is 30 years old this year, but as The New York Times recently spelled out , the program has become a profit engine for large health systems over the years instead of a program that helps vulnerable, low-income patients. Powerful hospitals have twisted the program to boost their bottom line.

Drug Pricing 118

Drug Pricing Hospitals 118

Drug Channels

DECEMBER 16, 2022

Here’s a summer surprise for fans of the 340B Drug Pricing Program: Drug Channels has just obtained the 2021 figures from the Health Resources and Services Administration (HRSA)! Hospitals accounted for 87% of these skyrocketing 340B purchases. Click here to see the original post and comments from August 2022.

Hospitals 97

Hospitals Drug Pricing 97

STAT

OCTOBER 26, 2022

In a nutshell, the 340B program allows certain federally funded health clinics (grantees) and nonprofit hospitals (covered entities) to buy drugs for their outpatients at prices typically only available to state Medicaid programs: an average discount of 25% to 50%, and often as low as a penny per dose.

Hospitals 251

Hospitals Drug Pricing 251

PhRMA

OCTOBER 6, 2022

The 340B Drug Pricing Program was designed to help vulnerable patients improve access to their medicines through manufacturer discounts to specific safety-net, non-profit hospitals and federally funded clinics.

Drug Pricing 123

Drug Pricing Hospitals 123